These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12473473)

  • 21. Success of MRSA eradication in hospital routine: depends on compliance.
    Hansen D; Patzke PI; Werfel U; Benner D; Brauksiepe A; Popp W
    Infection; 2007 Jun; 35(4):260-4. PubMed ID: 17646910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.
    Bertino JS
    Am J Health Syst Pharm; 1997 Oct; 54(19):2185-91. PubMed ID: 9331438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients.
    Kluytmans JA; Manders MJ; van Bommel E; Verbrugh H
    Infect Control Hosp Epidemiol; 1996 Dec; 17(12):793-7. PubMed ID: 8985765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
    Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
    Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
    Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.
    Miller MA; Dascal A; Portnoy J; Mendelson J
    Infect Control Hosp Epidemiol; 1996 Dec; 17(12):811-3. PubMed ID: 8985769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus.
    Parras F; Guerrero MC; Bouza E; Blázquez MJ; Moreno S; Menarguez MC; Cercenado E
    Antimicrob Agents Chemother; 1995 Jan; 39(1):175-9. PubMed ID: 7695302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal carriage of methicillin-resistant staphylococcus aureus in vascular surgery.
    Morange-Saussier V; Giraudeau B; van der Mee N; Lermusiaux P; Quentin R
    Ann Vasc Surg; 2006 Nov; 20(6):767-72. PubMed ID: 17086484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
    Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
    Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
    Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.
    Ammerlaan HS; Kluytmans JA; Berkhout H; Buiting A; de Brauwer EI; van den Broek PJ; van Gelderen P; Leenders SA; Ott A; Richter C; Spanjaard L; Spijkerman IJ; van Tiel FH; Voorn GP; Wulf MW; van Zeijl J; Troelstra A; Bonten MJ;
    J Antimicrob Chemother; 2011 Oct; 66(10):2418-24. PubMed ID: 21719471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections.
    Dupeyron C; Campillo SB; Mangeney N; Richardet JP; Leluan G
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):427-32. PubMed ID: 11583211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.
    Redhead RJ; Lamb YJ; Rowsell RB
    Br J Clin Pract; 1991; 45(4):252-4. PubMed ID: 1810357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.
    Wilcox MH; Hall J; Pike H; Templeton PA; Fawley WN; Parnell P; Verity P
    J Hosp Infect; 2003 Jul; 54(3):196-201. PubMed ID: 12855234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of high- and low-level mupirocin-resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals.
    Fujimura S; Watanabe A
    Chemotherapy; 2003 May; 49(1-2):36-8. PubMed ID: 12714808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
    Sandri AM; Dalarosa MG; Ruschel de Alcantara L; da Silva Elias L; Zavascki AP
    Infect Control Hosp Epidemiol; 2006 Feb; 27(2):185-7. PubMed ID: 16465636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRSA patients: proven methods to treat colonization and infection.
    Boyce JM
    J Hosp Infect; 2001 Aug; 48 Suppl A():S9-14. PubMed ID: 11759035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of the use of mupirocin nasal ointment on the incidence of endogenous MRSA infections in an intensive care unit].
    Hiramatsu N; Hashimoto S; Fujita N; Kageyama K; Ashida H; Kimura A; Kobayashi A; Tanaka Y
    Masui; 2000 Aug; 49(8):867-71. PubMed ID: 10998878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for development of methicillin-resistant Staphylococcus aureus-positive clinical culture in nasal carriers after decolonization treatment.
    Hernández-Porto M; Castro B; Ramos MJ; Arias A; Aguirre-Jaime A; Lecuona M
    Am J Infect Control; 2014 Jul; 42(7):e75-9. PubMed ID: 24855930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
    Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
    Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.